Retatrutide is a newly developed drug that acts as a powerful GLP-1 receptor agonist. This revolutionary method holds significant promise for regulating type 2 diabetes. By imitating the actions of natural GLP-1, Retatrutide boosts insulin secretion and suppresses glucagon release, leading to improved glucose control. Clinical trials have demonstra